Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Liver Cancer,2016,NIGMS,1P20GM113126-01,5964,Quantifying Biochemical Communication in Hepatocellular Carcinoma,"STAINS, CLIFF",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$180,126"
Liver Cancer,2016,NIGMS,1P20GM113226-01,6174,High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis,"DENG, ZHONG-BIN",UNIVERSITY OF LOUISVILLE,KY,"$184,680"
Liver Cancer,2016,NCI,5R01CA120206-11,,Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer,"MEHTA, ANAND",DREXEL UNIVERSITY,PA,"$329,172"
Liver Cancer,2016,NCI,4F30CA176922-03,,Recombinant Polymers for Transarterial Chemoembolization of Liver Cancer,"POURSAID, AZADEH",UNIVERSITY OF UTAH,UT,"$33,319"
Liver Cancer,2016,NCI,5R21CA185274-02,,Magnetic Micelles for Catheter-Directed Sorafenib Delivery to Liver Tumors,"KIM, DONG-HYUN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$201,623"
Liver Cancer,2016,NCI,5R01CA175380-03,,FoxM1 in liver cancer.,"RAYCHAUDHURI, PRADIP",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$405,146"
Liver Cancer,2016,NIDDK,5R01DK074932-10,,LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease,"HUI, DAVID",UNIVERSITY OF CINCINNATI,OH,"$355,500"
Liver Cancer,2016,NCI,5R01CA181658-02,,MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors,"LARSON, ANDREW",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$441,814"
Liver Cancer,2016,NIAAA,5P50AA011999-18,8467,Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4,"MACHIDA, KEIGO",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$203,571"
Liver Cancer,2016,NIEHS,5R21ES023906-02,,The antimicrobial triclosan is a potent liver tumor promoter,"YUEH, MEI-FEI",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$193,750"
Liver Cancer,2016,NCI,5R01CA193244-06,,Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice,"GHOSHAL, KALPANA",OHIO STATE UNIVERSITY,OH,"$368,367"
Liver Cancer,2016,NCI,2P30CA014089-41,8293,Gastrointestinal Cancers Research Program (Project-006),"KAHN, MICHAEL",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$35,512"
Liver Cancer,2016,NCI,4R01CA166111-04,,Tumor antigen-specific T-cells and hepatocellular carcinoma,"KAPLAN, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$332,000"
Liver Cancer,2016,NCI,5R01CA121275-08,,Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC),"LEONE, GUSTAVO",OHIO STATE UNIVERSITY,OH,"$316,102"
Liver Cancer,2016,NCI,5R01CA190844-02,,Hepatic Stellate Cells and Liver Cancer,"SCHWABE, ROBERT",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$358,306"
Liver Cancer,2016,NCI,5R01CA086978-13,,Molecular mechanism of diet-induced carcinogenesis,"JACOB, SAMSON",OHIO STATE UNIVERSITY,OH,"$311,850"
Liver Cancer,2016,NCI,5R01CA176012-03,,Molecular and cellular communications in liver tumorigenesis,"FENG, GEN-SHENG",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$321,625"
Liver Cancer,2016,NIAID,5R21AI118337-02,,Host and viral determinants of hepatitis C virus macaque infection,"EVANS, MATTHEW",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$263,629"
Liver Cancer,2016,NIGMS,9R01GM118122-16,,Metabolism of Carcinogens and Drugs by Human P450s,"GUENGERICH, F",VANDERBILT UNIVERSITY,TN,"$368,951"
Liver Cancer,2016,NIDDK,5R01DK098424-03,,Chemical probes targeting nuclear effector complex of the Hippo signaling pathway,"PAN, DUOJIA",JOHNS HOPKINS UNIVERSITY,MD,"$27,526"
Liver Cancer,2016,NCI,5R01CA190776-02,,A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis,"EL-SERAG, HASHEM",BAYLOR COLLEGE OF MEDICINE,TX,"$636,299"
Liver Cancer,2016,NCI,1R21CA190945-01A1,,Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma,"KASEB, AHMED",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$174,000"
Liver Cancer,2016,NCI,5R01CA168912-03,,Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines,"HE, YUKAI",GEORGIA REGENTS UNIVERSITY,GA,"$320,588"
Liver Cancer,2016,NCI,4U01CA172320-04,,Evaluation of HCC Response to Systemic Therapy with Quantitative MRI,"TAOULI, BACHIR",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$514,057"
Liver Cancer,2016,NIA,5R01AG016927-18,,The Role of Akt in Cell Survival and Cell Growth,"HAY, NISSIM",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$451,912"
Liver Cancer,2016,NCI,5R01CA185169-03,,Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics,"MCKNIGHT, STEVEN",UT SOUTHWESTERN MEDICAL CENTER,TX,"$475,351"
Liver Cancer,2016,NCI,4R01CA166213-05,,Super-infection and virus spread during chronic hepadnaviral infection,"GUDIMA, SEVERIN",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$319,945"
Liver Cancer,2016,NCI,1R03CA201988-01,,Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma,"TSAI, ROBERT",TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,TX,"$74,250"
Liver Cancer,2016,NIGMS,4R01GM059419-14,,Mitochondrial Calcium Signaling in Cell Death,"HAJNOCZKY, GYORGY",THOMAS JEFFERSON UNIVERSITY,PA,"$315,755"
Liver Cancer,2016,NIAAA,4R01AA012863-16,,Mechanisms of Liver Injury by Hepatitis C and Alcohol,"WEINMAN, STEVEN",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$516,577"
Liver Cancer,2016,NCI,4R01CA154986-04,,The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel,"STILES, BANGYAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$342,375"
Liver Cancer,2016,NCI,1R01CA194307-01A1,,2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization,"EISENBREY, JOHN",THOMAS JEFFERSON UNIVERSITY,PA,"$619,717"
Liver Cancer,2016,NCI,2R01CA102325-10A1,,15-PGDH in Cholangiocarcinogenesis,"WU, TONG",TULANE UNIVERSITY OF LOUISIANA,LA,"$344,269"
Liver Cancer,2016,NCI,4R01CA118165-10,,Role of Inflammation in tumor promotion and progression,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$446,701"
Liver Cancer,2016,NCI,5R03CA195183-02,,The role of Sirt2 in haptocarcinogenesis,"QIU, WEI",LOYOLA UNIVERSITY CHICAGO,IL,"$75,500"
Liver Cancer,2016,NCI,1R01CA184456-01A1,,VDAC Regulation of Warburg Metabolism in Hepatocarcinoma,"MALDONADO, EDUARDO",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$341,981"
Liver Cancer,2016,NCI,1R01CA202769-01,,Development of cell-free DNA assays for HCC screening and liquid biopsy,"SU, YING-HSIU",BARUCH S. BLUMBERG INSTITUTE,PA,"$432,900"
Liver Cancer,2016,NCI,4R01CA161694-05,,Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse,"SELL, STEWART",WADSWORTH CENTER,NY,"$292,725"
Liver Cancer,2016,NCI,5R01CA108614-10,,Novel targets that are deregulated by loss of PTEN,"JOHNSON, DEBORAH",BAYLOR COLLEGE OF MEDICINE,TX,"$288,103"
Liver Cancer,2016,NCI,5R01CA163287-05,,Carbonyls to Cancer Therapeutics,"CHAIN, WILLIAM",UNIVERSITY OF DELAWARE,DE,"$283,653"
Liver Cancer,2016,NCI,5R01CA188506-02,,Dissection of Pten-regulated signals in hepatopathogenesis,"FENG, GEN-SHENG",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$354,563"
Liver Cancer,2016,NIDDK,5R01DK104956-02,,Molecular Imaging of Liver Fibrosis,"FUCHS, BRYAN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$532,832"
Liver Cancer,2016,NCI,1R21CA202852-01,,DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER,"HELD, JASON",WASHINGTON UNIVERSITY,MO,"$152,500"
Liver Cancer,2016,NCI,4R01CA083650-14,,Altered Growth Factor Pathways in Biliary Cancer,"SIRICA, ALPHONSE",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$307,269"
Liver Cancer,2016,NCI,4R01CA164029-05,,Murine Model of HCV-Associated Human Liver Cancer,"LEMON, STANLEY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$470,695"
Liver Cancer,2016,NCI,5R21CA185943-02,,Beneficial effects of Honokiol against liver cancer,"SAXENA, NEERAJ",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$179,403"
Liver Cancer,2016,NCI,4R01CA080946-16,,Selenoproteins as targets for cancer prevention,"GLADYSHEV, VADIM",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$316,004"
Liver Cancer,2016,NCI,5R44CA196025-02,,Multifunctional Hollow Gold Nanospheres for Concurrent Photothermal-Chemotherapy,"WANG, Y","OCEAN NANOTECH, LLC",CA,"$500,000"
Liver Cancer,2016,NCI,5R01CA195787-02,,A scalable platform for target validation in GEMM models of gastrointestinal malignancies.,"LOWE, SCOTT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$648,617"
Liver Cancer,2016,NCI,7R01CA127387-09,,Role of the RB tumor suppressor in liver tumorigenesis,"KNUDSEN, ERIK",UNIVERSITY OF ARIZONA,AZ,"$400,509"
Liver Cancer,2016,NICHD,4R01HD024455-27,,Novel Approaches to Understanding the Nutrient Regulation of Fetal Somatic Growth,"GRUPPUSO, PHILIP",RHODE ISLAND HOSPITAL,RI,"$399,201"
Liver Cancer,2016,NCI,4R01CA165076-05,,Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma,"ROBERTS, LEWIS",MAYO CLINIC ROCHESTER,MN,"$327,228"
Liver Cancer,2016,NIDA,4R01DA034637-04,,Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics,"HAGAN, HOLLY",NEW YORK UNIVERSITY,NY,"$654,934"
Liver Cancer,2016,NIDDK,5R01DK054921-18,,Cyclin D1/CDK4 Complex in Hepatocyte Proliferation,"ALBRECHT, JEFFREY",UNIVERSITY OF MINNESOTA,MN,"$388,571"
Liver Cancer,2016,NCI,5R44CA165314-03,,A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC),"LU, XUANYONG",IMCARE BIOTECH,PA,"$657,468"
Liver Cancer,2016,NCI,5R21CA188472-02,,Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma,"RAY, RATNA",SAINT LOUIS UNIVERSITY,MO,"$177,066"
Liver Cancer,2016,NCI,5R01CA188305-02,,Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis,"XIAO, HUA",MICHIGAN STATE UNIVERSITY,MI,"$339,023"
Liver Cancer,2016,NIDDK,4R01DK059427-16,,Mechanisms of Carcinogenesis in Biliary Epithelia,"GORES, GREGORY",MAYO CLINIC ROCHESTER,MN,"$381,978"
Liver Cancer,2016,NIEHS,4P42ES010337-15,8807,Project 4: Antioxidant Protection by Bilirubin in Arsenic Induced Toxicity,"TUKEY, ROBERT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$289,934"
Liver Cancer,2016,NIEHS,4P42ES010337-15,5775,Project 1: Effects of Superfund Toxicants on Liver Cancer Progenitors,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$290,389"
Liver Cancer,2016,NCI,5R01CA190144-02,,Liver Cancer Risk with rAAV Gene Therapy,"GROMPE, MARKUS",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$636,568"
Liver Cancer,2016,NCI,5K08CA194268-02,,Novel targeted therapies for isocitrate dehydrogenase mutant cholangiocarcinoma,"SAHA, SUPRIYA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$179,280"
Liver Cancer,2016,NCATS,1R41TR001312-01A1,,Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists,"OUPICKY, DAVID","BOHEMICA PHARMACEUTICALS, LLC",NE,"$347,546"
Liver Cancer,2016,NCI,1R41CA195908-01A1,,Small molecule inhibitors targeting oncogenic drivers of hepatocellular carcinoma,"WAJAPEYEE, NARENDRA","L2 DIAGNOSTICS, LLC",CT,"$298,959"
Liver Cancer,2016,NIDDK,5R01DK102667-02,,Innovative Genetic Approaches for Hepatic Repopulation,"KAESTNER, KLAUS",UNIVERSITY OF PENNSYLVANIA,PA,"$360,000"
Liver Cancer,2016,NCI,5R01CA186566-02,,Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC),"HASSAN, MANAL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$657,227"
Liver Cancer,2016,NCI,1R01CA197081-01A1,,Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation,"AHMED, MUNEEB",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$440,786"
Liver Cancer,2016,NIDDK,1F31DK107254-01A1,,SRC-2 and AMPKa2 in liver metabolism and Non-Alcoholic Fatty Liver Disease,"FLEET, TIFFANY",BAYLOR COLLEGE OF MEDICINE,TX,"$43,576"
Liver Cancer,2016,NCI,5R01CA174735-03,,The role of MDM2-MTBP axis in cancer metastasis,"IWAKUMA, TOMOO",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$313,325"
Liver Cancer,2016,NCI,1R01CA200597-01A1,,HMGB1 as Link Between Hepatocellular Injury and HCC,"SCHWABE, ROBERT",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$458,761"
Liver Cancer,2016,NCI,4P01CA080124-15,6417,Overcoming Evasion from Sorafenib in HCC,"DUDA, DAN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$254,705"
Liver Cancer,2016,NCI,4P01CA080124-15,6421,Surgical and Animal Core,"FUKUMURA, DAI",MASSACHUSETTS GENERAL HOSPITAL,MA,"$436,627"
Liver Cancer,2016,NCI,4R01CA089121-10,,Hepatitis C Virus and Hepatocellular Carcinoma,"DASH, SRIKANTA",TULANE UNIVERSITY OF LOUISIANA,LA,"$237,038"
Liver Cancer,2016,NCI,5R01CA194574-02,,Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia,"LIAPI, ELENI",JOHNS HOPKINS UNIVERSITY,MD,"$659,622"
Liver Cancer,2016,NCI,4R01CA112192-09,,Real-time Ultrasonic Monitoring of Tumor Ablation,"VARGHESE, TOMY",UNIVERSITY OF WISCONSIN-MADISON,WI,"$249,074"
Liver Cancer,2016,NCI,5R01CA169919-05,,Metabolic control of hepatocellular carcinoma by PGC1alpha,"GIRNUN, GEOFFREY",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$359,587"
Liver Cancer,2016,NCI,5R01CA190525-02,,Reactivation of embryonic growth programs in liver cancer,"ZHU, HAO",UT SOUTHWESTERN MEDICAL CENTER,TX,"$370,194"
Liver Cancer,2016,NCI,4R01CA161209-06,,Functional Genomics and Molecular Imaging of Liver Disease and Cancer,"KWEE, SANDI",QUEEN'S MEDICAL CENTER,HI,"$325,386"
Liver Cancer,2016,NIBIB,4R01EB016960-04,,Pressure-Driven Local Drug Delivery System for Treatment of Liver Cancer,"EXNER, AGATA",CASE WESTERN RESERVE UNIVERSITY,OH,"$356,625"
Liver Cancer,2016,NCI,4R01CA114102-10,,The RB pathway in liver cancer,"SAGE, JULIEN",STANFORD UNIVERSITY,CA,"$278,578"
Liver Cancer,2016,NCI,5R01CA164335-06,,An Orthotopic Murine Model of HCC: Immunotolerance and Prevention,"STAVELEY-O'CARROLL, KEVIN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$301,525"
Liver Cancer,2016,NCI,5R01CA190678-02,,Mechanisms of obesity-induced hepatocarcinogenesis,"CHUNG, FUNG-LUNG",GEORGETOWN UNIVERSITY,DC,"$364,322"
Liver Cancer,2016,NCI,5P01CA059827-18,5908,Response-driven Treatment of Hepatocellular Carcinoma,"LAWRENCE, THEODORE",UNIVERSITY OF MICHIGAN,MI,"$342,669"
Liver Cancer,2016,NCI,4R01CA172713-04,,PATTERNS OF r AAV VECTOR INSERTION ASSOCIATED WITH LIVER TUMORS IN A MOUSE MODEL,"MCCARTY, DOUGLAS",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$303,988"
Liver Cancer,2016,NIBIB,5R01EB018849-03,,Ultrasound-Guided Robotic Needle Steering for Ablation of Liver Cancer,"OKAMURA, ALLISON",STANFORD UNIVERSITY,CA,"$361,256"
Liver Cancer,2016,NCI,5F32CA192633-02,,Disruption of the Host DNA Damage Response by Hepatitis C Virus,"MITCHELL, JONATHAN",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$32,484"
Liver Cancer,2016,NCI,5R21CA191814-02,,"Autophagy, mTOR inhibitors and phenformin in hepatocellular carcinoma","MERCER, CAROL",UNIVERSITY OF CINCINNATI,OH,"$184,663"
Liver Cancer,2016,NCI,5R01CA194533-02,,Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity,"HETTS, STEVEN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$522,926"
Liver Cancer,2016,NCI,5R01CA181566-02,,Compact Representations of Dynamic Liver MRI,"SPINCEMAILLE, PASCAL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$387,731"
Liver Cancer,2016,NCI,5R21CA198490-02,,Glutamine catabolism in c-Myc driven liver tumor development,"CHEN, XIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$206,843"
Liver Cancer,2016,NCI,1P01CA203628-01,7232,Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression,"BRITTEN, CAROLYN",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$541,564"
Liver Cancer,2016,NIDDK,1R01DK108743-01,,Control of stellate cells-driven liver cancer by the p62/NBR1 adapters,"MOSCAT, JORGE",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$454,727"
Liver Cancer,2016,NCI,1R01CA204586-01,,Yap and beta-catenin interactions in liver: Implications in Pathophysiology,"MONGA, SATDARSHAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$425,315"
Liver Cancer,2016,NCI,1R01CA203985-01,,Mechanism of Met-Induced Hepatocyte Survival,"ZARNEGAR, REZA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$352,275"
Liver Cancer,2016,NCI,5R01CA051497-25,,MYC--Transcription and Apoptosis,"DANG, CHI",UNIVERSITY OF PENNSYLVANIA,PA,"$733,273"
Liver Cancer,2016,NCI,1R01CA204373-01,,Imaging Liver Cancer Proliferation,"LEE, ZHENGHONG",CASE WESTERN RESERVE UNIVERSITY,OH,"$321,679"
Liver Cancer,2016,NIDDK,4R01DK100287-04,,"Targeting beta-catenin in liver pathology: Novel Interactions, Novel Paradigms","MONGA, SATDARSHAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$328,340"
Liver Cancer,2016,NCI,4P30CA046592-28,6463,Gastrointestinal Oncology,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$194,891"
Liver Cancer,2016,NIAAA,5U01AA022614-03,,The Role of IL-17 in Alcoholic Liver Disease and Cancer,"KISSELEVA, TATIANA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$353,250"
Liver Cancer,2016,NIBIB,1R21EB022298-01,,3D Passive Cavitation Imaging-Guided Therapeutic Delivery of MicroRNA into Cancer,"WILLMANN, JUERGEN",STANFORD UNIVERSITY,CA,"$195,444"
Liver Cancer,2016,NIAID,5R21AI113394-02,,Hepatitis B virus transcriptional interference and liver cancer-related mutations,"TONG, SHUPING",RHODE ISLAND HOSPITAL,RI,"$241,500"
Liver Cancer,2016,NIBIB,1R21EB022291-01,,Transarterial Immunomodulatory Embolization: A novel approach to cancer therapy,"AMEER, GUILLERMO",NORTHWESTERN UNIVERSITY,IL,"$238,870"
Liver Cancer,2016,NCI,5R01CA183764-02,,The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle,"GRADILONE, SERGIO",UNIVERSITY OF MINNESOTA,MN,"$348,844"
Liver Cancer,2016,NCI,5R01CA163805-06,,Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans,"JUON, HEE-SOON",THOMAS JEFFERSON UNIVERSITY,PA,"$330,974"
Liver Cancer,2016,NCI,5R01CA172086-03,,PROHIBITIN 1 IN LIVER INJURY AND CANCER,"LU, SHELLY",CEDARS-SINAI MEDICAL CENTER,CA,"$312,404"
Liver Cancer,2016,NIBIB,1R01EB022148-01,,Cancer-specific nanoparticle-mediated gene therapy to treat hepatocellular carcinoma,"GREEN, JORDAN",JOHNS HOPKINS UNIVERSITY,MD,"$364,500"
Liver Cancer,2016,NCCIH,5R01AT001576-14,,Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease,"LU, SHELLY",CEDARS-SINAI MEDICAL CENTER,CA,"$297,230"
Liver Cancer,2016,NCI,5R01CA182264-03,,Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer,"PAN, XIAOCHUAN",UNIVERSITY OF CHICAGO,IL,"$443,731"
Liver Cancer,2016,NCI,5R01CA196967-02,,MRI-Guided Irreversible Electroporation Ablation for Liver Tumors,"ZHANG, ZHUOLI",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$347,209"
Liver Cancer,2016,NIDDK,5R01DK107288-02,,S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment,"LU, SHELLY",CEDARS-SINAI MEDICAL CENTER,CA,"$393,750"
Liver Cancer,2016,NIAAA,5R01AA023146-11,,Role of Beta Spectrin and Smad in Alcohol Induced Liver and GI Cell Proliferation,"MISHRA, LOPA",GEORGE WASHINGTON UNIVERSITY,DC,"$285,300"
Liver Cancer,2016,NCI,5P30CA142543-07,6364,Population Science and Cancer Control Scientific Program,"WILLSON, JAMES",UT SOUTHWESTERN MEDICAL CENTER,TX,"$53,100"
Liver Cancer,2016,NCI,5K08CA172288-05,,Mechanisms and modifiers of beta-catenin-induced hepatic tumorigenesis,"EVASON, KIMBERLEY",UNIVERSITY OF UTAH,UT,"$150,763"
Liver Cancer,2016,NIDDK,4R01DK097249-04,,"Med1 in Liver Metabolism, Regeneration and Cancer","THIMMAPAYA, BAYAR",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$336,038"
Liver Cancer,2016,NCI,1R21CA205501-01,,Developing Therapy for the Treatment of Cholangiocarcinoma,"YOON, KARINA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$191,835"
Liver Cancer,2016,NCI,1R01CA190606-01A1,,Signaling cascades in cholangiocarcinoma development,"CHEN, XIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$362,569"
Liver Cancer,2016,NCI,4R01CA180083-04,,(PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip,"QIN, LIDONG",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$505,194"
Liver Cancer,2016,NCI,5R01CA203565-02,,Nutritional Control of Cancer Cell Function by Amino Acids,"KILBERG, MICHAEL",UNIVERSITY OF FLORIDA,FL,"$343,125"
Liver Cancer,2016,NCI,5R01CA197128-02,,Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis,"QIU, WEI",LOYOLA UNIVERSITY CHICAGO,IL,"$351,229"
Liver Cancer,2016,NCI,5R03CA184531-02,,Murine Models on SALL4 in Hepatocellular Carcinoma,"CHAI, LI",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$81,775"
Liver Cancer,2016,NIDDK,2R01DK090311-06,,Estrogen Regulation of Hepatic Growth,"GOESSLING, WOLFRAM",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$637,107"
Liver Cancer,2016,NCI,4R01CA164719-05,,Role of liver fluke granulin in cholangiocarcinogenesis,"BRINDLEY, PAUL",GEORGE WASHINGTON UNIVERSITY,DC,"$328,400"
Liver Cancer,2016,NCI,1R01CA195524-01A1,,Early Detection of Hepatocellular Carcinoma,"BERETTA, LAURA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$645,417"
Liver Cancer,2016,NCI,3R01CA062130-20S1A1,,Role of Heat Shock transcription factor HSF1 in tumorigenesis,"MIVECHI, NAHID",GEORGIA REGENTS UNIVERSITY,GA,"$142,120"
Liver Cancer,2016,NCI,5R01CA200007-02,,Multiplexed imaging of biliary intra-epithelial neoplasia,"SEIBEL, ERIC",UNIVERSITY OF WASHINGTON,WA,"$589,117"
Liver Cancer,2016,NIDDK,5R01DK100490-04,,GENETICALLY MODIFIED HEPATOCYTES TO ACHIEVE SUCCESS IN LIVER CELL TRANSPLANTATION,"SHAFRITZ, DAVID","ALBERT EINSTEIN COLLEGE OF MEDICINE, INC",NY,"$667,576"
Liver Cancer,2016,NIEHS,5R01ES025909-02,,Molecular Basis of Cancer Cell Metabolic Reprogramming,"WANG, LI",UNIVERSITY OF CONNECTICUT STORRS,CT,"$355,500"
Liver Cancer,2016,NIAID,5P50AI098639-05,6987,Pathogenesis of Opisthorchiasis induced persistent periductal fibrosis and CCA,"SRIPA, BANCHOB",KHON KAEN UNIVERSITY,THAIL,"$168,141"
Liver Cancer,2016,NIAID,5P50AI098639-05,6988,Opisthorchis Viverrini ES Proteins and the Tumorgenic Environment,"LAHA, THEWARACH",KHON KAEN UNIVERSITY,THAIL,"$112,596"
Liver Cancer,2016,NCI,5K08CA193915-02,,The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome,"KALISH, JENNIFER",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$140,504"
Liver Cancer,2016,NCI,5R01CA196692-02,,Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?,"IOANNOU, GEORGE",SEATTLE INST FOR BIOMEDICAL/CLINICAL RES,WA,"$209,012"
Liver Cancer,2016,NCI,1R01CA200310-01A1,,Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma,"MACLEOD, KAY",UNIVERSITY OF CHICAGO,IL,"$397,573"
Liver Cancer,2016,NCI,1R01CA198103-01A1,,ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma,"KAUFMAN, RANDAL",SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE,CA,"$765,053"
Liver Cancer,2016,NIDDK,4R01DK093646-05,,Identifying and modulating therapeutic targets in a model of  hepatitis B,"BARON, JODY","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$344,738"
Liver Cancer,2016,NCI,5R01CA062130-21,,Role of heat shock transcription factor HSF1 in tumoroginesis,"MIVECHI, NAHID",GEORGIA REGENTS UNIVERSITY,GA,"$556,510"
Liver Cancer,2016,NCI,5U01CA185188-02,,Analysis of Racial Disparities in HCC by Systems Metabolomics,"RESSOM, HABTOM",GEORGETOWN UNIVERSITY,DC,"$255,915"
Liver Cancer,2016,NCI,5U01CA188387-02,,Gut microbiota mediated bile acid alterations in hepatic carcinogenesis,"JIA, WEI",UNIVERSITY OF HAWAII AT MANOA,HI,"$571,982"
Liver Cancer,2016,NIDDK,4K01DK099405-04,,Identifying a role for commensal bacteria on the liver immune priming environment,"PUBLICOVER, JEAN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$143,014"
Liver Cancer,2016,NIDDK,4K01DK097291-04,,Deleted in liver cancer 1 (DLC1) in liver development and disease,"SHIH, YI-PING",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$117,873"
Liver Cancer,2016,NCI,5U01CA179582-03,,The Role of Probiotic Bifidobacteria and Bile Acid Metabolism in Carcinogenesis,"WAN, YU-JUI",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$530,656"
Liver Cancer,2016,NCI,5R01CA135069-07,,Glycans in Hepatocellular Carcinoma,"GOLDMAN, RADOSLAV",GEORGETOWN UNIVERSITY,DC,"$403,705"
Liver Cancer,2016,NCI,5R01CA136606-08,,Molecular Genetics of Liver Cancers,"CHEN, XIN","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$356,625"
Liver Cancer,2016,RMAP,4U19CA179512-04,7166,Function of Extracellular Small RNAs in Conditional Mouse Models of Liver Cancer,"BLELLOCH, ROBERT","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$135,553"
Liver Cancer,2016,NCI,5R01CA172230-03,,TREM-1 and Its Implications to Cancer,"HORUZSKO, ANATOLIJ",GEORGIA REGENTS UNIVERSITY,GA,"$315,400"
Liver Cancer,2016,NCI,4U01CA168856-05,,Aberrantly secreted glycoproteins as markers of liver cancer,"MEHTA, ANAND",DREXEL UNIVERSITY,PA,"$289,144"
Liver Cancer,2016,NCI,5K99CA191152-02,,Development of mosaic mouse models of HCC for genetic interspecies inference,"FONT-BURGADA, JOAN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$109,620"
Liver Cancer,2016,NCI,4R01CA177686-04,,Regulation of molecular thermal ablative resistance in hepatocellular carcinoma,"WOODRUM, DAVID",MAYO CLINIC ROCHESTER,MN,"$329,925"
Liver Cancer,2016,NCI,5K22CA184146-03,,Metabolic reprogramming in liver cancer cells by a novel tumor suppressor,"ZHANG, YUXIA",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$118,152"
Liver Cancer,2016,RMAP,5UH3TR000884-04,,Extracellular non-coding RNA biomarkers of hepatocellular cancer,"PATEL, TUSHAR",MAYO CLINIC  JACKSONVILLE,FL,"$986,936"
Liver Cancer,2016,NCI,1R01CA206465-01,,(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer,"JUSTICE, AMY",YALE UNIVERSITY,CT,"$563,374"
Liver Cancer,2016,NCI,5K07CA197179-02,,Genetic and Environmental Risk of Liver Disease/Cancer among Mexicans,"FLORES, YVONNE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$160,920"
Liver Cancer,2016,NCI,5F31CA200373-02,,Injectable Implants for Increased Tumor Treatment Volume Using Pressure Driven Diffusion,"HERNANDEZ, CHRISTOPHER",CASE WESTERN RESERVE UNIVERSITY,OH,"$32,765"
Liver Cancer,2016,NIDDK,5K01DK106346-02,,Altered endosomal protein sorting in the pathogenesis of hepatocellular carcinoma,"SINGLA, AMIKA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$124,040"
Liver Cancer,2016,FIC,5U54CA190165-03,7860,Adminstrative and Coordinating Core,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$8,131"
Liver Cancer,2016,NCI,5U54CA190165-03,7860,Adminstrative and Coordinating Core,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$113,817"
Liver Cancer,2016,FIC,5U54CA190165-03,7861,The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$11,952"
Liver Cancer,2016,NCI,5U54CA190165-03,7861,The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$167,311"
Liver Cancer,2016,FIC,5U54CA190165-03,7862,Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$14,853"
Liver Cancer,2016,NCI,5U54CA190165-03,7862,Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$207,911"
Liver Cancer,2016,FIC,5U54CA190165-03,7863,Biomarker and Analytical Core,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$8,991"
Liver Cancer,2016,NCI,5U54CA190165-03,7863,Biomarker and Analytical Core,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$125,855"
Liver Cancer,2016,FIC,5U54CA190165-03,7874,Developmental Core,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$6,073"
Liver Cancer,2016,NCI,5U54CA190165-03,7874,Developmental Core,"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$85,006"
Liver Cancer,2016,NIDDK,4R01DK099558-04,,Molecular Prognostic Indicators in Liver Cirrhosis and Cancer,"HOSHIDA, YUJIN",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$683,136"
Liver Cancer,2016,NCI,1R43CA206683-01,,A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC),"GROSS, COLEMAN","EIGER GROUP INTERNATIONAL, INC.",CA,"$267,105"
Liver Cancer,2016,NCI,2R44CA186410-02A1,,Optimization of a clinical stage nanoparticle drug delivery platform,"BROWN, BOB","DICERNA PHARMACEUTICALS, INC.",MA,"$1,000,000"
Liver Cancer,2016,NCI,4U01CA168926-05,,Alliance of Glycobiologists for Detection of Cancer,"GOLDMAN, RADOSLAV",GEORGETOWN UNIVERSITY,DC,"$505,313"
Liver Cancer,2016,NCI,4R01CA172302-04,,Genetics pathways in intra-hepatic cholangiocarcinoma,"HEZEL, ARAM",UNIVERSITY OF ROCHESTER,NY,"$318,513"
Liver Cancer,2016,NCI,5R44CA162783-03,,"CC49/RIGS, a diagnostic radiopharmaceutical monoclonal antibody, for enhanced liv","COPE, FREDERICK","NAVIDEA BIOPHARMACEUTICALS, INC.",OH,"$688,135"
Liver Cancer,2016,NCI,5R44CA195793-02,,Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors,"PARETTE, MYLISA","KEYSTONE NANO, INC.",PA,"$942,527"
Liver Cancer,2016,NCI,5P30CA196521-02,7061,Liver Cancer (LC) (Project-003),"FRIEDMAN, SCOTT",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$10,690"
Liver Cancer,2016,NCI,5DP5OD021391-02,,Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology,"GADE, TERENCE",UNIVERSITY OF PENNSYLVANIA,PA,"$399,999"
Liver Cancer,2016,NIDCR,5DP5OD021391-02,,Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology,"GADE, TERENCE",UNIVERSITY OF PENNSYLVANIA,PA,$1
Liver Cancer,2016,NCI,5U54CA193417-02,7363,"Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology: Administrative Core","DISCHER, DENNIS",UNIVERSITY OF PENNSYLVANIA,PA,"$386,364"
Liver Cancer,2016,NCI,5U54CA193417-02,7364,Core 1: Cell and Tissue Core,"WELLS, REBECCA",UNIVERSITY OF PENNSYLVANIA,PA,"$267,114"
Liver Cancer,2016,NCI,5U54CA193417-02,7365,Core 2: Theory Core - Multiscale models for mechano-chemical phenomena,"LIU, ANDREA",UNIVERSITY OF PENNSYLVANIA,PA,"$280,471"
Liver Cancer,2016,NCI,5U54CA193417-02,7366,Project 1:  Mechanisms of Stiffening in Liver Cancer,"DISCHER, DENNIS",UNIVERSITY OF PENNSYLVANIA,PA,"$352,015"
Liver Cancer,2016,NCI,5U54CA193417-02,7367,Project 2: Physical Mechanisms and Clinical Implications of Mechano-transduction,"RADHAKRISHNAN, RAVI",UNIVERSITY OF PENNSYLVANIA,PA,"$326,372"
Liver Cancer,2016,NCI,5U54CA193417-02,7368,Project 3:  Nuclear Rheology & Stability in Cancer,"DISCHER, DENNIS",UNIVERSITY OF PENNSYLVANIA,PA,"$339,195"
Liver Cancer,2016,NCI,5U54CA193417-02,7369,PSOC@Penn Education and Outreach,"DISCHER, DENNIS",UNIVERSITY OF PENNSYLVANIA,PA,"$143,098"
Liver Cancer,2016,NCI,1R56CA207929-01,,Cellular Pathogenesis of Fibrolamellar Hepatocellular Carcinoma,"SIMON, SANFORD",ROCKEFELLER UNIVERSITY,NY,"$296,625"
Liver Cancer,2016,NCI,2R01CA160254-05,,Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach,"LUBMAN, DAVID",UNIVERSITY OF MICHIGAN,MI,"$374,611"
Liver Cancer,2016,NIDDK,1R01DK107451-01A1,,The role of AEG-1 in NASH and NASH-HCC,"SARKAR, DEVANAND",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$363,258"
Liver Cancer,2016,NCI,1R01CA201127-01A1,,Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology,"CRESSMAN, ERIK",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$372,942"
Liver Cancer,2016,NIDDK,1R01DK106395-01A1,,Metabolic imaging of nonalcoholic fatty liver disease,"MAYER, DIRK",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$579,504"
Liver Cancer,2016,NCI,1R21CA201867-01A1,,Neurotensin in Fibrolamellar Liver Cancer,"RIEHLE, KIMBERLY",UNIVERSITY OF WASHINGTON,WA,"$168,019"
Liver Cancer,2016,NCI,2R01CA080024-19,,Intra and Extra-Chromosomal Probes for Mutagenesis by Carcinogens,"ESSIGMANN, JOHN",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$342,076"
Liver Cancer,2016,NIDDK,1R01DK105198-01A1,,Metabolic Regulation of Liver Growth,"GOESSLING, WOLFRAM",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$547,130"
Liver Cancer,2016,NIDDK,1R01DK103735-01A1,,Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B,"COOPER, STEWART",CALIFORNIA PACIFIC MED CTR RES INSTITUTE,CA,"$795,453"
Liver Cancer,2016,NCI,1R21CA202396-01A1,,The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development,"KOLTSOVA, EKATERINA",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$232,943"
Liver Cancer,2016,NIDDK,7R01DK100289-03,,Signaling Pathways Influencing Liver Disease Phenotype in Antitrypsin Deficiency,"PERLMUTTER, DAVID",WASHINGTON UNIVERSITY,MO,"$460,770"
Liver Cancer,2016,NCI,1R01CA206180-01A1,,Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment,"GESCHWIND, JEAN-FRANCOIS",YALE UNIVERSITY,CT,"$669,786"
Liver Cancer,2016,NIAID,1F32AI126660-01,,RNA-Protein Interactions During Hepatitis C Virus Infection,"ADAMS, REBECCA",YALE UNIVERSITY,CT,"$54,294"
Liver Cancer,2016,NCI,4R00CA190783-02,,Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers,"SCHIAVINATO EBERLIN, LIVIA","UNIVERSITY OF TEXAS, AUSTIN",TX,"$248,966"
Liver Cancer,2016,NIDDK,1F32DK109651-01A1,,Mechanisms of differential susceptibility to nonalcoholic fatty liver disease,"RIORDAN, JESSE",PACIFIC NORTHWEST RESEARCH INSTITUTE,WA,"$56,118"
Liver Cancer,2016,NIAAA,1F32AA025271-01,,The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinoma,"WRIGHTON, PAUL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$54,294"
Liver Cancer,2016,NCI,1F31CA210639-01,,Improving Sorafenib; a multi-targeted kinase inhibitor used for the treatment of hepatocellular carcinoma by mechanistically dissecting out its underlying targets and anti-targets,"YU, JIA",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$40,776"
Liver Cancer,2016,NCI,1R01CA204145-01A1,,Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort,"HUSSAIN, SHEHNAZ",CEDARS-SINAI MEDICAL CENTER,CA,"$440,818"
Liver Cancer,2016,NCI,1R01CA206167-01A1,,Hexokinase 2 in liver cancer,"HAY, NISSIM",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$398,154"
Liver Cancer,2016,NCI,3R01CA193244-06S1,,Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice,"GHOSHAL, KALPANA",OHIO STATE UNIVERSITY,OH,"$61,549"
Liver Cancer,2016,NCI,7R01CA164335-05,,An Orthotopic Murine Model of HCC: Immunotolerance and Prevention,"STAVELEY-O'CARROLL, KEVIN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$197,336"
Liver Cancer,2016,NCI,1R44CA203276-01A1,,Development and testing of MRI-mediated radiofrequency ablation system and probes,"NEVO, EREZ","ROBIN MEDICAL, INC.",MD,"$749,066"
Liver Cancer,2016,NCI,2R42CA168123-02A1,,In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma,"GHANDEHARI, HAMID",THERATARGET,UT,"$400,462"
Liver Cancer,2016,RMAP,1R03CA211210-01,,A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C+ Individuals,"SPRATT, HEIDI",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$155,000"
Liver Cancer,2016,NIBIB,1R01EB022075-01A1,,Imaging and Dosimetry of Yttrium-90 for Personalized Cancer Treatment,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN,MI,"$461,991"
Liver Cancer,2016,NCI,3R43CA192850-01S1,,Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions,"STICE, JIM","TWIN STAR TDS, LLC",KY,"$40,000"
Liver Cancer,2016,NCI,1R43CA213610-01,,Urine DNA Kit for monitoring HCC recurrence,"JAIN, SURBHI","JBS SCIENCE, INC.",PA,"$300,000"
Liver Cancer,2016,RMAP,4UH3TR000914-04,,Targeted delivery of microRNA-loaded microvesicle for cancer therapy,"SCHMITTGEN, THOMAS",UNIVERSITY OF FLORIDA,FL,"$800,677"
Liver Cancer,2016,NIDDK,1F32DK111151-01A1,,A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation,"WALESKY, CHAD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$56,118"
Liver Cancer,2016,NCI,3U01CA185188-02S1,,Analysis of Racial Disparities in HCC by Systems Metabolomics,"RESSOM, HABTOM",GEORGETOWN UNIVERSITY,DC,"$193,780"
Liver Cancer,2016,NCI,3R21CA188472-02S1,,Establishment of PDX mouse models and cell lines from hepatitis C virus associated liver cancer patients from CA and AA ethnic groups,"RAY, RATNA",SAINT LOUIS UNIVERSITY,MO,"$199,954"
Liver Cancer,2016,RMAP,3UH3TR000884-04S1,,Extracellular non-coding RNA biomarkers of hepatocellular cancer,"PATEL, TUSHAR",MAYO CLINIC  JACKSONVILLE,FL,"$10,955"
Liver Cancer,2016,RMAP,3UH3TR000914-04S1,,Targeted delivery of microRNA-loaded microvesicle for cancer therapy,"SCHMITTGEN, THOMAS",UNIVERSITY OF FLORIDA,FL,"$62,500"
Liver Cancer,2016,NIDDK,3R01DK107288-02S1,,S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment,"LU, SHELLY",CEDARS-SINAI MEDICAL CENTER,CA,"$27,564"
Liver Cancer,2016,NIDDK,7R01DK098424-04,,Chemical probes targeting nuclear effector complex of the Hippo signaling pathway,"PAN, DUOJIA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$324,824"
Liver Cancer,2016,NCI,3DP2CA195764-01S1,,Oncolytic Virotherapy in Hepatocellular Cancer,"BORAD, MITESH",MAYO CLINIC ARIZONA,AZ,"$219,502"
Liver Cancer,2016,NCI,1ZIACP005782-22,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$251,756"
Liver Cancer,2016,NCI,1ZIACP010127-21,,Etiologic Studies of Diet and Cancer,"FREEDMAN, NEAL",NIH,,"$61,954"
Liver Cancer,2016,NCI,1ZIACP010128-21,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"TRABERT, BRITTON",NIH,,"$206,904"
Liver Cancer,2016,NCI,1ZIACP010158-16,,Studies of Rare Cancers,"MCGLYNN, KATHERINE",NIH,,"$582,056"
Liver Cancer,2016,NCI,1ZIACP010184-14,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$1,770,645"
Liver Cancer,2016,NCI,1ZIABC005793-22,,Mechanism of viral hepatitis-mediated hepatocarcinogenesis,"WANG, XIN",NIH,,"$111,437"
Liver Cancer,2016,NCI,1ZIABC010297-19,,Identification of Genetic Factors Associated with Infectious Diseases,"WINKLER, CHERYL",NIH,,"$462,474"
Liver Cancer,2016,NCI,1ZIABC010313-18,,Molecular signatures for liver cancer diagnosis and treatment stratification,"WANG, XIN",NIH,,"$891,493"
Liver Cancer,2016,NCI,1ZIABC010793-10,,"Role of inflammation, innate resistance, and immunity in carcinogenesis","TRINCHIERI, GIORGIO",NIH,,"$1,078,868"
Liver Cancer,2016,NCI,1ZIABC010876-09,,The role of cancer stem cells in liver cancer heterogeneity and subtypes,"WANG, XIN",NIH,,"$891,493"
Liver Cancer,2016,NCI,1ZIABC010877-09,,The identification of human hepatocellular carcinoma metastasis genes,"WANG, XIN",NIH,,"$334,310"
Liver Cancer,2016,NCI,1ZIABC010891-09,,Development of new antibody-based cancer therapies,"HO, MITCHELL",NIH,,"$1,192,823"
Liver Cancer,2016,NCI,1ZIABC011343-07,,Clinical protocols for the treatment of gastrointestinal cancer,"GRETEN, TIM",NIH,,"$199,565"
Liver Cancer,2016,NCI,1ZIDBC011540-03,,Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core,"HASSAN, RAFFIT",NIH,,"$2,214,926"
Liver Cancer,2016,NICHD,1ZIAHD008804-10,,The Role of Carboxypeptidase E in Cancer,"LOH, YOKE",NIH,,"$609,044"
Liver Cancer,2016,NIEHS,1ZIAES103166-04,,DNA Microarray Data Analysis,"SHOCKLEY, KEITH",NIH,,"$97,458"
Liver Cancer,2016,NIAID,1ZIAAI000999-10,,Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases,"FARCI, PATRIZIA",NIH,,"$1,253,600"
Liver Cancer,2016,NCI,261201600058C-0-0-1,,IGF::OT::IGF CELL-FREE CIRCULATING DBA-BASED ASSAY DEVELOPMENT FOR LIVER CANCER SCREENING,"JAIN, SURBHI","JBS SCIENCE, INC.",PA,"$273,600"
Liver Cancer,2016,NCATS,1ZIATR000118-02,,NPC/MIPE Toxicity Screen of IDH1 Inhibitors against Cholangiocarcinoma Cell Lines,"HALL, MATTHEW",NIH,,"$37,474"
